Chemours – Q1 Earnings Beat; Q2 Guidance Below Consensus
Key Points Q1’26 EBITDA and EPS beat on strong TSS segment results Q2’26 guidance range midpoint below consensus estimates We rate CC shares Overweight with a 12-month target price of ......
ALEMBIC GLOBAL ADVISORS
Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.We Are
EQUITY RESEARCH ADVISORS
2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
We Have
VALUABLE INSIGHT
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
We Offer
UNIQUE MARKET PERSPECTIVE
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Get in touch with us to learn more about working with Alembic Global Advisors.
LATEST NEWS
RESEARCH REPORTS
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
- May 5, 2026
- May 5, 2026
Celanese – Slight Q1 Earnings Miss but Q2 Guidance Significantly Above Consensus. FCF Guidance Raised
Key Points Below-consensus Q1’26 EBITDA and EPS. Q2 guidance above consensus primarily on the back of AC segment strength FY2026 FCF guidance raised to USD700-800m from USD650-750m We have an ......
- May 5, 2026
Westlake Corporation – Q1 EBITDA and EPS Miss
Key Points Q1’26 EPS and EBITDA miss on PEM segment weakness Management’s near-term commentary positive We rate WLK shares Overweight with a 12-month target price of USD120 Summary Westlake Corporation ......
- May 4, 2026
WWD: Increasing Forecast & Target Price Post 2QFY26 as Execution Matching Market Tailwinds
Key Points We are raising our forecast for WWD post 2QFY26 earnings last week and we’re reiterating our Overweight rating on the shares. Our target price rises USD10 to USD448 ......
- May 1, 2026
LyondellBasell – Q1 Earnings Beat and Positive Q2 Commentary
Key Points Q1’26 EBITDA and EPS beat Near-term outlook commentary positive We rate LYB shares Overweight with a 12-month target price of USD100 per share Summary LyondellBasell announced Q1’26 results ......
- May 1, 2026
GD: Increasing Forecast & Target Price Post Solid 1Q26
Key Points We are raising our forecast for GD post the firm’s 1Q26 earnings report earlier this week, and we’re also raising our target price, though we’re maintaining our Neutral ......